TransCode Therapeutics, Inc. (RNAZ)

TransCode Therapeutics Market Cap

TransCode Therapeutics has a market cap or net worth of $3.01 million as of April 25, 2024. Its market cap has decreased by -52.24% in one year.

• Market Cap: 3.01M
• Enterprise Value: 638.19K
• 1-Year Change: -52.24%
• Ranking: #5533
• Category: Nano-Cap
• Stock Price: $0.46

Market Cap Chart

Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $3.01M, a decrease of -93.71%. That is a compound annual growth rate of -62.85%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	2.60M	-3.70%
Apr 23, 2024	2.70M	-
Apr 22, 2024	2.70M	-3.57%
Apr 19, 2024	2.80M	-3.45%
Apr 18, 2024	2.90M	-
Apr 17, 2024	2.90M	-
Apr 16, 2024	2.90M	-6.45%
Apr 15, 2024	3.10M	-13.89%
Apr 12, 2024	3.60M	-2.70%
Apr 11, 2024	3.70M	-
Apr 10, 2024	3.70M	-
Apr 9, 2024	3.70M	-2.63%
Apr 8, 2024	3.80M	2.70%
Apr 5, 2024	3.70M	-5.13%
Apr 4, 2024	3.90M	2.63%
Apr 3, 2024	3.80M	-5.00%
Apr 2, 2024	4.00M	-
Apr 1, 2024	4.00M	42.86%
Mar 28, 2024	2.80M	-
Mar 27, 2024	2.80M	3.70%
Mar 26, 2024	2.70M	-3.57%
Mar 25, 2024	2.80M	3.70%
Mar 22, 2024	2.70M	-3.57%
Mar 21, 2024	2.80M	-3.45%
Mar 20, 2024	2.90M	3.57%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Catheter Precision	3.45M
Revelation Biosciences	3.38M
Innovative Eyewear	3.29M
Windtree Therapeutics	3.24M
Phio Pharmaceuticals	3.21M
SciSparc	3.01M
60 Degrees Pharmaceuticals	2.90M
ENDRA Life Sciences	2.81M